PA
NOMD icon

PharVision Advisers’s Nomad Foods NOMD Stock Holding History

PharVision Advisers’s Portfolio NOMD Stock Details NOMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-15,240
Closed -$200K – 905
2025
Q3 		$200K Sell
15,240
-3,852
-20% -$60.3K 0.11% 519
2025
Q2 		$324K Sell
19,092
-139
-0.7% -$2.55K 0.47% 65
2025
Q1 		$378K Sell
19,231
-17,383
-47% -$318K 0.52% 47
2024
Q4 		$614K Buy
+36,614
New +$640K 0.52% 24

Other funds holding NOMD

Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

PharVision Advisers's NOMD Position: Q4 2025 in Review

PharVision Advisers sold out of Nomad Foods (NOMD) in Q4 2025, closing a stake of 15,240 shares — an estimated $200K sold.

PharVision Advisers first reported a position in NOMD in Q4 2024 and held it in 4 quarters. The position peaked at $614K in Q4 2024. 193 funds tracked by Wall St. Rank hold NOMD as of Q4 2025.

  • PharVision Advisers reported no remaining Nomad Foods position as of Q4 2025 after selling out during the quarter.
  • PharVision Advisers sold 15,240 Nomad Foods shares in Q4 2025, an estimated $200K.
  • PharVision Advisers first reported a position in Nomad Foods in Q4 2024 and held it in 4 quarters.
  • PharVision Advisers's Nomad Foods position peaked at $614K in Q4 2024.
  • 193 funds tracked by Wall St. Rank held Nomad Foods as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.